重新审视战场创伤黄金一小时政策
该回顾性分析纳入2001年9月11日至2014年3月31日在阿富汗受伤的4542名军人伤员,评估国防部长罗伯特·M·盖茨要求60分钟内后送命令后阵亡死亡率下降的 proposed 解释。采用逆概率加权和多变量逻辑回归及模拟分析,发现时间趋势不显著,而需要并接受院前输血、前方外科团队初始治疗、特定部位损伤、钝性机制和1小时内后送均与阵亡死亡率降低相关。模拟显示若后送时间未改变,阵亡死亡率将比观察值高1.4%,相当于多135例阵亡。结论认为阵亡死亡率降低与早期治疗能力、钝性机制、特定损伤部位和快速后送相关。
要点
- 对于军事损伤严重度评分≥25的伤员,需要并接受院前输血者阵亡死亡 odds 降低83%(AOR 0.17;95%CI 0.06-0.51;p=0.002)。
- 接受前方外科团队初始治疗者阵亡死亡 odds 降低33%(AOR 0.67;95%CI 0.58-0.78;p<0.001)。
- 1小时内后送者阵亡死亡 odds 降低39%(AOR 0.61;95%CI 0.51-0.74;p<0.001)。
- 模拟显示若命令后后送时间未改变,阵亡死亡率将比观察值高1.4%,相当于多135例阵亡(95%CI 105-164)。
- 时间趋势(逐步改善)与阵亡死亡率无显著关联(AOR 0.99;95%CI 0.94-1.03;p=0.58)。
适用人群与场景
- 2001年9月11日至2014年3月31日在阿富汗受伤的4542名军事伤员,为回顾性分析人群。
诊断标准与关键阈值
- 军事损伤严重度评分(military Injury Severity Score)≥25定义为严重创伤亚组,用于分析院前输血、前方外科团队治疗等效应。
研究设计与关键结果
- 研究类型为回顾性分析,纳入4542名在阿富汗受伤的军事伤员,采用逆概率加权处理选择偏倚,使用多变量逻辑回归和模拟分析评估五种解释对院亡死亡率的影响。
- 时间趋势(逐步改善)与阵亡死亡率无显著关联(AOR 0.99;95%CI 0.94-1.03;p=0.58)。
- 军事损伤严重度评分≥25的伤员中,需要并接受院前输血者阵亡死亡 odds 降低83%(AOR 0.17;95%CI 0.06-0.51;p=0.002)。
- 军事损伤严重度评分≥25的伤员中,接受前方外科团队初始治疗者阵亡死亡 odds 降低33%(AOR 0.67;95%CI 0.58-0.78;p<0.001)。
- 军事损伤严重度评分≥25的伤员中,头部、腹部和四肢为主要损伤部位者阵亡死亡 odds 分别降低70%(AOR 0.30;95%CI 0.23-0.38;p<0.001)、74%(AOR 0.26;95%CI 0.19-0.36;p<0.001)和87%(AOR 0.13;95%CI 0.09-0.17;p<0.001)。
- 钝性损伤者阵亡死亡 odds 降低35%(AOR 0.65;95%CI 0.46-0.92;p=0.01)。
- 1小时内后送者阵亡死亡 odds 降低39%(AOR 0.61;95%CI 0.51-0.74;p<0.001)。
- 模拟分析显示若命令后后送时间未改变,阵亡死亡率将比观察值高1.4%,相当于多135例阵亡(95%CI 105-164)。
证据类型、等级与局限
- 证据类型为回顾性分析,证据等级为治疗性研究III级。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为阵亡死亡率降低与早期治疗能力、钝性机制、特定损伤部位和快速后送相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Most combat casualties who die, do so in the prehospital setting. Efforts directed toward alleviating prehospital combat trauma death, known as killed in action (KIA) mortality, have the greatest opportunity for eliminating preventable death.
METHODS: Four thousand five hundred forty-two military casualties injured in Afghanistan from September 11, 2001, to March 31, 2014, were included in this retrospective analysis to evaluate proposed explanations for observed KIA reduction after a mandate by Secretary of Defense Robert M. Gates that transport of injured service members occur within 60 minutes. Using inverse probability weighting to account for selection bias, data were analyzed using multivariable logistic regression and simulation analysis to estimate the effects of (1) gradual improvement, (2) damage control resuscitation, (3) harm from inadequate resources, (4) change in wound pattern, and (5) transport time on KIA mortality.
RESULTS: The effect of gradual improvement measured as a time trend was not significant (adjusted odds ratio [AOR], 0.99; 95% confidence interval [CI], 0.94-1.03; p = 0.58). For casualties with military Injury Severity Score of 25 or higher, the odds of KIA mortality were 83% lower for casualties who needed and received prehospital blood transfusion (AOR, 0.17; 95% CI, 0.06-0.51; p = 0.002); 33% lower for casualties receiving initial treatment by forward surgical teams (AOR, 0.67; 95% CI, 0.58-0.78; p < 0.001); 70%, 74%, and 87% lower for casualties with dominant injuries to head (AOR, 0.30; 95% CI, 0.23-0.38; p < 0.001), abdomen (AOR, 0.26, 95% CI, 0.19-0.36; p < 0.001) and extremities (AOR, 0.13; 95% CI, 0.09-0.17; p < 0.001); 35% lower for casualties categorized with blunt injuries (AOR, 0.65; 95% CI, 0.46-0.92; p = 0.01); and 39% lower for casualties transported within one hour (AOR, 0.61; 95% CI, 0.51-0.74; p < 0.001). Results of simulations in which transport times had not changed after the mandate indicate that KIA mortality would have been 1.4% higher than observed, equating to 135 more KIA deaths (95% CI, 105-164).
CONCLUSION: Reduction in KIA mortality is associated with early treatment capabilities, blunt mechanism, select body locations of injury, and rapid transport.
LEVEL OF EVIDENCE: Therapy, level III.
参考来源
- Howard JT, Kotwal RS, Santos-Lazada AR, et al. Reexamination of a Battlefield Trauma Golden Hour Policy. J Trauma Acute Care Surg. 2018. PMID: 29266051. doi:10.1097/TA.0000000000001727
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。